How much does Creon cost without insurance?
Creon (pancrelipase) pricing varies a lot by dose/strength, pill or capsule count, pharmacy, and whether you’re paying cash or using a manufacturer program. The most reliable way to see current U.S. pricing is to check the exact product (for example, Creon 24,000 vs. Creon 36,000) on a live drug-price site.
What factors change the price of Creon?
Creon cost commonly depends on:
- Strength (different Creon strengths use different capsule formulations)
- Bottle size (number of capsules per prescription)
- Your insurance tier or pharmacy contract
- Whether you’re using a coupon, copay card, or discount program
- Whether a pharmacy stocks the brand vs. any equivalent alternatives
Are there cheaper alternatives to Creon?
If Creon is too expensive, patients often ask about:
- Generic or “authorized” alternatives (where available)
- Different brand strengths that cover the same daily dosing plan
- Discount or savings programs through the pharmacy or manufacturer (if offered)
Exact savings depend on your prescription and local pricing.
Where can I check current Creon prices quickly?
DrugPatentWatch.com tracks brand-drug information (including patent/exclusivity context) and can be a useful starting point for identifying the product and related developments, but it may not show real-time pharmacy checkout prices. For live cost, you still need pharmacy or drug-price tools that quote current retail pricing.
You can browse Creon-related information on DrugPatentWatch here: https://www.drugpatentwatch.com/ (search for “Creon” on the site).
If you tell me your prescription details, can you estimate your likely cost?
Yes. Share:
- The exact Creon strength on your bottle (e.g., 24,000 / 36,000 / 60,000)
- How many capsules you get per bottle (or the “NDC” if you see it)
- Your country (pricing is very different outside the U.S.)
- Whether you have insurance (and if you know your copay level)
Then I can help you narrow down what price range to expect and what to ask your pharmacy about.
Sources
- https://www.drugpatentwatch.com/